Literature DB >> 12764379

Patterns of BCR/ABL gene rearrangements by interphase fluorescence in situ hybridization (FISH) in BCR/ABL+ leukemias: incidence and underlying genetic abnormalities.

D Primo1, M D Tabernero, A Rasillo, J M Sayagués, A B Espinosa, M C Chillón, R Garcia-Sanz, N Gutierrez, M Giralt, A Hagemeijer, J F San Miguel, A Orfao.   

Abstract

Interphase fluorescence in situ hybridization (iFISH) is increasingly used for the identification of BCR/ABL gene rearrangements in chronic myeloid leukemia (CML) and acute lymphoblastic leukemia (ALL). In the present study, we have explored the incidence of both typical and atypical iFISH patterns of BCR/ABL gene rearrangements in a series of 168 consecutive BCR/ABL+ patients--135 CML, 31 precursor B-ALL and two acute myeloblastic leukemia (AML) cases--and established their underlying genetic alterations through further molecular and chromosome analyses. Two different FISH probes (Vysis Inc., Downers Grove, IL, USA) were used: the LSI BCR/ABL dual color extra signal (ES) and the dual color dual fusion BCR/ABL probe (D-FISH). Our results show that most BCR/ABL+ patients (83%, including 88% of all CML, 61% of ALL and one of two AML) displayed typical iFISH patterns of either Major (M) BCR/ABL (87% of CML, 13% of ALL and one of the two AML) or minor (m) BCR/ABL gene rearrangements (1% of all CML and 48% of ALL cases) with the two probes. Further molecular and cytogenetic studies confirmed the presence of such typical rearrangements in all except one of these ALL cases who had coexistence of an MBCR/ABL and an mBCR/ABL gene rearrangement together with monosomy 9. In the remaining 29 cases (17%), up to five different atypical iFISH patterns were detected with the ES probe. Atypical iFISH patterns were most frequently due to additional numerical changes--most often supernumerary Philadelphia (Ph) chromosome (7%) but also gain or loss of chromosome 9 (1%) or 22 (1%). Deletion of 9q sequences proximal to the breakpoint were also frequently observed with the ES probe (8%). Application of the D-FISH probe showed that in most of these latter cases (5%) deletion of 22q sequences distal to the breakpoint also occurred. The remaining cases with atypical iFISH had cryptic insertion of BCR in 9q34 (1%). Exact interpretation of each iFISH pattern was supported by FISH on metaphases and molecular determination of the BCR breakpoint. In summary, our results indicate that despite the high incidence of typical iFISH patterns of BCR/ABL gene rearrangements, atypical patterns are also found in BCR/ABL+ acute leukemias; the precise definition of the alteration present in individual cases is dependent on metaphase studies and molecular definition of the breakpoint.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12764379     DOI: 10.1038/sj.leu.2402963

Source DB:  PubMed          Journal:  Leukemia        ISSN: 0887-6924            Impact factor:   11.528


  8 in total

1.  Diagnostic molecular pathology, part 2: proteomics and clinical applications of molecular diagnostics in hematopathology.

Authors:  Georges J Netto; Rana Saad
Journal:  Proc (Bayl Univ Med Cent)       Date:  2005-01

2.  Chronic myeloid leukemia with insertion-derived BCR-ABL1 fusion: redefining complex chromosomal abnormalities by correlation of FISH and karyotype predicts prognosis.

Authors:  Zhenya Tang; Gokce A Toruner; Guilin Tang; C Cameron Yin; Wei Wang; Shimin Hu; Beenu Thakral; Sa A Wang; Roberto N Miranda; Joseph D Khoury; L Jeffrey Medeiros
Journal:  Mod Pathol       Date:  2020-05-13       Impact factor: 7.842

3.  Diagnostic algorithms, monitoring, prognostication, and therapy in chronic myeloid leukemia (CML): a proposal of the Austrian CML platform.

Authors:  Peter Valent; Thomas Lion; Dominik Wolf; Christian Sillaber; Hermine Agis; Andreas Petzer; Alois Lang; Peter Kalhs; Dietmar Geissler; Richard Greil; Werner Linkesch; Sonja Burgstaller; Josef Thaler; Günther Gastl
Journal:  Wien Klin Wochenschr       Date:  2008       Impact factor: 1.704

4.  An unusual case of high hyperdiploid childhood ALL with cryptic BCR/ABL1 rearrangement.

Authors:  Libuse Lizcova; Zuzana Zemanova; Halka Lhotska; Jan Zuna; Lenka Hovorkova; Ester Mejstrikova; Eva Malinova; Jana Rabasova; Ivan Raska; Lucie Sramkova; Jan Stary; Kyra Michalova
Journal:  Mol Cytogenet       Date:  2014-10-24       Impact factor: 2.009

5.  ADAM8 Is an Antigen of Tyrosine Kinase Inhibitor-Resistant Chronic Myeloid Leukemia Cells Identified by Patient-Derived Induced Pluripotent Stem Cells.

Authors:  Masashi Miyauchi; Junji Koya; Shunya Arai; Sho Yamazaki; Akira Honda; Keisuke Kataoka; Akihide Yoshimi; Kazuki Taoka; Keiki Kumano; Mineo Kurokawa
Journal:  Stem Cell Reports       Date:  2018-02-08       Impact factor: 7.765

6.  Heterogeneous BCR-ABL1 signal patterns identified by fluorescence in situ hybridization are associated with leukemic clonal evolution and poorer prognosis in BCR-ABL1 positive leukemia.

Authors:  Zhanglin Zhang; Zhiwei Chen; Mei Jiang; Shuyuan Liu; Yang Guo; Lagen Wan; Fei Li
Journal:  BMC Cancer       Date:  2019-10-08       Impact factor: 4.430

7.  Application of tri-colour, dual fusion fluorescence in situ hybridization (FISH) system for the characterization of BCR-ABL1 fusion in chronic myelogenous leukaemia (CML) and residual disease monitoring.

Authors:  Lisa Lp Siu; Edmond Sk Ma; Wai Shan Wong; Man Hong Chan; Kit Fai Wong
Journal:  BMC Blood Disord       Date:  2009-07-07

8.  Multi-Lineage BCR-ABL Expression in Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia Is Associated With Improved Prognosis but No Specific Molecular Features.

Authors:  Satoshi Nishiwaki; Jeong Hui Kim; Masafumi Ito; Matsuyoshi Maeda; Yusuke Okuno; Daisuke Koyama; Yukiyasu Ozawa; Masaharu Gunji; Masahide Osaki; Kunio Kitamura; Yoko Ushijima; Yuichi Ishikawa; Koichi Miyamura; Isamu Sugiura; Hitoshi Kiyoi
Journal:  Front Oncol       Date:  2020-10-23       Impact factor: 6.244

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.